ENCOD
  • Donate
  • Covid-19 messages
  • News
  • Organisation
    • About us
    • Our Team
      • WORKING GROUPS
      • STUDIES
      • GENERAL ASSEMBLIES
      • FINANCES
    • Our Mission
    • FAQ
    • IN THE PRESS
    • ANNUAL REPORTS
    • ENCOD MEMBERS
    • INFO FOR MEMBERS
  • Join us
  • Actions & Events
    • CAMPAIGNS
      • FREEDOM TO FARM
        • FREEDOM TO FARM
        • FREEDOM TO FARM IS THE FIRST TEST OF RELIGIOUS FREEDOM
        • FREEDOM TO FARM AND CANNABIS SOCIAL CLUBS FOR PEOPLE WHO USE CANNABIS AS A MEDICINE
        • FREEDOM TO FARM POSTERS
        • FREEDOM TO FARM STICKERS
      • Cannabis Social Clubs
        • HOW TO CREATE A CANNABIS SOCIAL CLUB
        • EXAMPLES OF CSC’S IN EUROPE
        • Cannabis Social Clubs in Aktion
        • PROPOSAL TO REGULATE THE SELF CULTIVATION AND CANNABIS SOCIAL CLUBS IN BELGIUM
        • Catalonia regulates the Cannabis Social Clubs
        • WORKSHOP ‘HOW TO SET UP A CSC IN GERMANY’
      • 2017
      • 2014
      • 2010 – 2013
      • 2009
      • 2008
      • 2007
      • 2006
      • 1995 – 2005
      • EU LOBBY CAMPAIGN
        • 2011
        • 2010
        • 2009
        • 2008
        • 2007
        • 2006
        • 2005
        • 2004
    • ACTION APPEALS
  • Bulletins
  • Video Archive
  • Donate
  • Covid-19 messages
  • News
  • Organisation
    • About us
    • Our Team
      • WORKING GROUPS
      • STUDIES
      • GENERAL ASSEMBLIES
      • FINANCES
    • Our Mission
    • FAQ
    • IN THE PRESS
    • ANNUAL REPORTS
    • ENCOD MEMBERS
    • INFO FOR MEMBERS
  • Join us
  • Actions & Events
    • CAMPAIGNS
      • FREEDOM TO FARM
        • FREEDOM TO FARM
        • FREEDOM TO FARM IS THE FIRST TEST OF RELIGIOUS FREEDOM
        • FREEDOM TO FARM AND CANNABIS SOCIAL CLUBS FOR PEOPLE WHO USE CANNABIS AS A MEDICINE
        • FREEDOM TO FARM POSTERS
        • FREEDOM TO FARM STICKERS
      • Cannabis Social Clubs
        • HOW TO CREATE A CANNABIS SOCIAL CLUB
        • EXAMPLES OF CSC’S IN EUROPE
        • Cannabis Social Clubs in Aktion
        • PROPOSAL TO REGULATE THE SELF CULTIVATION AND CANNABIS SOCIAL CLUBS IN BELGIUM
        • Catalonia regulates the Cannabis Social Clubs
        • WORKSHOP ‘HOW TO SET UP A CSC IN GERMANY’
      • 2017
      • 2014
      • 2010 – 2013
      • 2009
      • 2008
      • 2007
      • 2006
      • 1995 – 2005
      • EU LOBBY CAMPAIGN
        • 2011
        • 2010
        • 2009
        • 2008
        • 2007
        • 2006
        • 2005
        • 2004
    • ACTION APPEALS
  • Bulletins
  • Video Archive
March 17, 2012  |  By ENCOD In 2010 - 2013

IMPRESSIONS FROM VIENNA PART 4

arton3621

Impressions from the Encod delegation at the UN CND in Vienna

Part 3

Boaz Wachtel

16 march 2012


Dear friends,

Vienna UN event was a fascinating lesson of the International Drug Policy real politics and an understanding of the dynamics of power of the “war on Drugs”, our relative strength (or weakness) and current positions among NGO’s and world’s governments on drug issues.

First I wish to thank our Austrian friends who helped organise the demonstration (small but important), and the Press conference, to the Rototom folks who helped with the music truck, the Italian delegation who showed up in force and to all those who helped in the event.

The time in Vienna was excellent opportunity to finally meet ENCOD’s steering committee co-members and have the opportunity to strategize with them on tactics and strategies related to our issues. Farid, Fredrick and Enrico, Frantik – thanks and love to your direction.

I will not go into too many details but the impression from within is that there are ways (albeit difficult) to influence drug policy after you learn the power structures and the interaction between the players.

Most work should be directed to national level representatives who have the power to suggest changes and amendments on specific issues to drug resolutions. For example – the Israeli delegation, in collaboration with the Czech Republic (the EU sponsor) offered a resolution (that was adopted) to reduce overdose related deaths among heroine/opiate IVDU with Nalaxone. Nalaxone is an opiate antagonist that brings addicts out of OD (if used in the right time) by blocking the opiate receptors and antagonising the analgesic effect of the opiates. It can be injected by a friend and it should be distributed not just to hospitals and emergency crews but also to addicts who usually hang out in small groups.

We were able to directly challenge the top people of the CND (council of Narcotic Drugs) and UNODC (UN office of Drug Control).

In the “dialogue with NGO’s” the Spanish chair-women Carmen Buyan Friere was asked by me something like this “When you talk about collaboration with NGO’s you must expect that there are plurality of opinions among the NGO’s. We ask therefore to include the minority opinion in all papers involving NGO’s in order to reflect plurality of opinions on the issue of drug policy and avoid the dictatorship of majority of opinion”. She was a bit positive and said they will consider it – I am not sure if they will incorporate the change but we put it on the table.

We also were able to ask the Russian chairman of the UNODC the following question:
“in UNODC’s discussion paper from January 2011 titled “Ensuring availability of controlled medications for the relief of pain and preventing diversion and abuse” its written on the severe lack of availability of controlled medications for pain (opiate based). Few rich countries consume the vast majority of opiate based medications and 50 million people a year have no access to any type of pain medication.

Therefore I suggested to him that medical cannabis could be used as a pain medication for cancer and other types pain”. The chairman said that the UN conventions allow the for the medical use of scheduled drugs but must maintain a balance to prevent diversion.

In order to make medical cannabis available for those who cannot access opiate based medications on a global scale, WHO should recognise the medical use/value of Cannabis plant (not just single or multiple cannabinoids). For WHO to study the issue, a country or a few countries, signatories to UN drug conventions, should send a request to WHO to do so.

After a study by WHO, they would recommend CND to adopt measures to allow access to medical cannabis under controlled programs, as currently being implemented in a number of countries.

I have approached already officials in the Israeli Medical cannabis program for Israel to lead the way and request WHO to submit a request for study in order to start an international dynamics to resolve this great misery of many poor people around the world. I do hope they will cooperate in this important, life saving issue.

Boaz Wachtel

SC Member

Previous StoryRESOCONTO DA VIENNA
Next StoryDAS KOKABLATT HAT FREUNDE IN EUROPA

Related Articles

  • vicvienna.jpg
    UN COMMISSION ON NARCOTIC DRUGS
  • Ljubljana_07112012_0073.jpg
    ENCOD TRIP TO SLOVENIA AND CZECH REPUBLIC

Categories

Archives

  • About us
  • Downloads
  • Contact
  • Privacy Policy
  • Legal Notice & Terms of Use
  • Imprint

Copyright ©2018 ThemeFuse. All Rights Reserved

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT

REPUBLISHING TERMS

You may republish this article online or in print under our Creative Commons license. You may not edit or shorten the text, you must attribute the article to ENCOD and you must include the author’s name in your republication.

If you have any questions, please email thujer@gmail.com

License

Creative Commons License AttributionCreative Commons Attribution
IMPRESSIONS FROM VIENNA PART 4